Detalles de la búsqueda
1.
Bhlhe40 Promotes CD4+ T Helper 1 Cell and Suppresses T Follicular Helper Cell Differentiation during Viral Infection.
J Immunol;
2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38619295
2.
Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.
Blood;
137(9): 1241-1255, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33027805
3.
Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1- Terminal Effectors during the Progression of Type 1 Diabetes.
J Immunol;
207(8): 1990-2004, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507949
4.
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
Blood;
135(8): 568-581, 2020 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31880771
5.
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells.
J Am Chem Soc;
142(40): 16953-16964, 2020 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902974
6.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant;
26(5): 893-901, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982543
7.
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
26(10): 1876-1885, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653622
8.
Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD.
Blood;
132(4): 435-447, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769260
9.
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
25(8): 1689-1694, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30965140
10.
Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.
Biol Blood Marrow Transplant;
25(1): e33-e38, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244105
11.
Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.
Biol Blood Marrow Transplant;
25(4): 827-833, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572109
12.
Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
Int J Cancer;
143(4): 886-896, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29524208
13.
Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome.
Biol Blood Marrow Transplant;
24(8): 1664-1670, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680516
14.
Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.
Blood;
128(16): 2068-2082, 2016 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488350
15.
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Haematologica;
108(1): 250-256, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106394
16.
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease.
Haematologica;
103(4): 717-727, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29351985
17.
Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.
Carcinogenesis;
38(1): 86-93, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27866157
18.
Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome.
Biol Blood Marrow Transplant;
23(11): 1955-1960, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28757436
19.
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
Biol Blood Marrow Transplant;
23(8): 1295-1302, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28412518
20.
Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease.
Biol Blood Marrow Transplant;
22(12): 2141-2148, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27596131